Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...

Some of our favorite fruits and vegetables carry unhealthy levels of chemicals. CR's exclusive ratings reveal how to get the ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

Once those prices are set, most large government programs that cover prescription drugs pay prices that are tied to ...

The best value and growth stocks can balance risk and return and are reasonably priced and positioned with room to grow.

Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ?? Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ?? Updated 2025 Full Year Guidan ...

Capricor Therapeutics finds itself navigating turbulent waters as a federal securities class action lawsuit casts uncertainty over the company's future. The legal investigation, made public on October ...

Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; potentially relevant in up to 5% of all solid tumors ...

Bristol-Myers Squibb Company BMY reported third-quarter 2025 adjusted earnings per share (EPS) of $1.63, which comfortably ...